Aberrant upregulation of 14-3-3ơ expression serves as an inferior prognostic biomarker for gastric cancer

Hypermethylated 14-3-3-σ and ESR1 gene promoters in serum as candidate biomarkers for the diagnosis and treatment efficacy of breast cancer metastasis

(2012) Mercedes Zurita et al.   BMC CANCER

14-3-3 σ Expression Effects G2/M Response to Oxygen and Correlates with Ovarian Cancer Metastasis

(2011) Dashnamoorthy Ravi et al.   PLoS One

Elevated Beclin 1 expression is correlated with HIF-1α in predicting poor prognosis of nasopharyngeal carcinoma

(2010) Xiang-Bo Wan et al.   Autophagy

Role of 14-3-3σ in poor prognosis and in radiation and drug resistance of human pancreatic cancers

(2010) Zhaomin Li et al.   BMC CANCER

Human epidermal growth factor receptor 2 (HER2) in gastric cancer: a new therapeutic target

(2010) F. De Vita et al.   CANCER TREATMENT REVIEWS

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

(2010) Yung-Jue Bang et al.   LANCET

BMI1 and Mel-18 oppositely regulate carcinogenesis and progression of gastric cancer

(2010) Xiao-Wei Zhang et al.   Molecular Cancer

SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients

(2009) Z.-S. Zhao et al.   CLINICAL CANCER RESEARCH

Inactivation of 14-3-3 σ by promoter methylation correlates with metastasis in nasopharyngeal carcinoma

(2009) Bin Yi et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Identification of Novel Nasopharyngeal Carcinoma Biomarkers by Laser Capture Microdissection and Proteomic Analysis

(2008) A.-L. Cheng et al.   CLINICAL CANCER RESEARCH

14-3-3  Modulates Pancreatic Cancer Cell Survival and Invasiveness

(2008) D. Neupane et al.   CLINICAL CANCER RESEARCH

High Expression of HER3 Is Associated with a Decreased Survival in Gastric Cancer

(2008) M. Hayashi et al.   CLINICAL CANCER RESEARCH

Inverse Association between Raf Kinase Inhibitory Protein and Signal Transducers and Activators of Transcription 3 Expression in Gastric Adenocarcinoma Patients: Implications for Clinical Outcome

(2008) D. Chatterjee et al.   CLINICAL CANCER RESEARCH